Concerning the article by s. Belda et Al.: screening for retinopathy of prematurity: is it painful?

Biology of the neonate Pub Date : 2006-01-01 Epub Date: 2005-11-15 DOI:10.1159/000089754
José Figueras-Aloy, J Manuel Rodríguez-Miguélez, M Dolors Salvia-Roiges, Francesc Botet-Mussons
{"title":"Concerning the article by s. Belda et Al.: screening for retinopathy of prematurity: is it painful?","authors":"José Figueras-Aloy, J Manuel Rodríguez-Miguélez, M Dolors Salvia-Roiges, Francesc Botet-Mussons","doi":"10.1159/000089754","DOIUrl":null,"url":null,"abstract":"Therefore, we consider that it is as important to relieve the pain as to prevent systemic effects of mydriatics in low-weight infants [3] . The main prophylactic measures are [4] : (1) To use in neonates only the minimum effective concentration of drugs: 2% ophthalmic phenylephrine solution and 0.5% ophthalmic cyclopentolate solution. (2) To reduce systemic absorption of drugs by applying pressure to the lacrimal sac during and for 2 min after instillation. Without lacrimal sac occlusion, approximately 80% of each drop may pass through the nasolacrimal system and be available for rapid systemic absorption by the nasal mucosa. To perform this correctly, two persons are needed: one for applying pressure to the lacrimal sac and the other for instilling the drops. (3) Not to repeat the doses. Usually it is enough to instill one drop of each drug in the eye at least 10 min prior funduscopic procedures, especially if lacrimal sac occlusion is complete. This procedure can be exceptionally repeated 15 min later, but a third dose should never be given. Dear Sir, We read with interest the article by Belda et al. ‘Screening for retinopathy of prematurity: Is it painful?’ [Biol Neonate 2004; 86: 195–200]. We agree with its content but we have a few concerns about some of the information presented in the above referenced article [1] and about practical recommendations that have not been included for neonatologists and nurses taking care of the preterm infants. The objective of the study was to evaluate the ophthalmologic examination side effects in preterm neonates with specially focusing on the occurrence of pain. Gastrointestinal side effects (vomiting and gastric aspirates), minimum oxygen saturation, apneas, and the need for respiratory assistance or intensive care unit admission within 24 h after the examination were assessed. These late clinical side effects are probably not due to pain but to the instillation of mydriatics, as the same authors refer to in the Discussion. These changes on physiologic variables may be life-threatening and can produce, although rarely, a cardiorespiratory arrest [2] . Published online: November 15, 2005","PeriodicalId":9091,"journal":{"name":"Biology of the neonate","volume":"89 3","pages":"197; author reply 198"},"PeriodicalIF":0.0000,"publicationDate":"2006-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000089754","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biology of the neonate","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1159/000089754","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2005/11/15 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Therefore, we consider that it is as important to relieve the pain as to prevent systemic effects of mydriatics in low-weight infants [3] . The main prophylactic measures are [4] : (1) To use in neonates only the minimum effective concentration of drugs: 2% ophthalmic phenylephrine solution and 0.5% ophthalmic cyclopentolate solution. (2) To reduce systemic absorption of drugs by applying pressure to the lacrimal sac during and for 2 min after instillation. Without lacrimal sac occlusion, approximately 80% of each drop may pass through the nasolacrimal system and be available for rapid systemic absorption by the nasal mucosa. To perform this correctly, two persons are needed: one for applying pressure to the lacrimal sac and the other for instilling the drops. (3) Not to repeat the doses. Usually it is enough to instill one drop of each drug in the eye at least 10 min prior funduscopic procedures, especially if lacrimal sac occlusion is complete. This procedure can be exceptionally repeated 15 min later, but a third dose should never be given. Dear Sir, We read with interest the article by Belda et al. ‘Screening for retinopathy of prematurity: Is it painful?’ [Biol Neonate 2004; 86: 195–200]. We agree with its content but we have a few concerns about some of the information presented in the above referenced article [1] and about practical recommendations that have not been included for neonatologists and nurses taking care of the preterm infants. The objective of the study was to evaluate the ophthalmologic examination side effects in preterm neonates with specially focusing on the occurrence of pain. Gastrointestinal side effects (vomiting and gastric aspirates), minimum oxygen saturation, apneas, and the need for respiratory assistance or intensive care unit admission within 24 h after the examination were assessed. These late clinical side effects are probably not due to pain but to the instillation of mydriatics, as the same authors refer to in the Discussion. These changes on physiologic variables may be life-threatening and can produce, although rarely, a cardiorespiratory arrest [2] . Published online: November 15, 2005
关于s. Belda等人的文章:筛查早产儿视网膜病变:痛苦吗?
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信